Evofem Biosciences
San Diego
About Evofem Biosciences
Evofem is a biopharmaceutical company that offers women's reproductive and contraceptive care products. The company's first commercial product, Phexxi, is the first and only hormone-free, prescription vaginal gel approved in the United States to prevent pregnancy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Total funding: $471.8M
- Funding stage: M&A
- Last round: Post-IPO Equity (May 2024)
- Ticker: otcqb:EVFM
- Website: evofem.com
- Phone: (858)-550-1900
Industries & Categories
Biopharma, Health Care, Medical, Women's
Social Profiles
Canonical: https://fsome.com/organization/evofem-biosciences-63952 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.